Dicesium;1-(5-bromo-1,2-benzoxazol-3-yl)-3-[(4-methoxyphenyl)methyl]-1,3-diazinane-2,4-dione;carbonate
C20H16BrCs2N3O7 — CID 175793688
Data last refreshed: (MolForge compound catalog, from PubChem)
About Dicesium;1-(5-bromo-1,2-benzoxazol-3-yl)-3-[(4-methoxyphenyl)methyl]-1,3-diazinane-2,4-dione;carbonate
Dicesium;1-(5-bromo-1,2-benzoxazol-3-yl)-3-[(4-methoxyphenyl)methyl]-1,3-diazinane-2,4-dione;carbonate (PubChem CID 175793688) has the molecular formula C20H16BrCs2N3O7 and a molecular weight of 756.08 g/mol. Its IUPAC name is dicesium;1-(5-bromo-1,2-benzoxazol-3-yl)-3-[(4-methoxyphenyl)methyl]-1,3-diazinane-2,4-dione;carbonate.
Molecular Properties
| Compound Name | Dicesium;1-(5-bromo-1,2-benzoxazol-3-yl)-3-[(4-methoxyphenyl)methyl]-1,3-diazinane-2,4-dione;carbonate |
|---|---|
| PubChem CID | 175793688 |
| Molecular Formula | C20H16BrCs2N3O7 |
| Molecular Weight | 756.08 g/mol |
| Exact Mass | 754.83 |
| IUPAC Name | dicesium;1-(5-bromo-1,2-benzoxazol-3-yl)-3-[(4-methoxyphenyl)methyl]-1,3-diazinane-2,4-dione;carbonate |
| SMILES | COc1ccc(CN2C(=O)CCN(c3noc4ccc(Br)cc34)C2=O)cc1.O=C([O-])[O-].[Cs+].[Cs+] |
| InChI | InChI=1S/C19H16BrN3O4.CH2O3.2Cs/c1-26-14-5-2-12(3-6-14)11-23-17(24)8-9-22(19(23)25)18-15-10-13(20)4-7-16(15)27-21-18;2-1(3)4;;/h2-7,10H,8-9,11H2,1H3;(H2,2,3,4);;/q;;2*+1/p-2 |
| InChIKey | BRQVCEWKDHHXCW-UHFFFAOYSA-L |
| XLogP | -4.48 |
| TPSA | 139.07 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 756.08 |
| LogP ≤ 5 | -4.48 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 175793688 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.